STOCKHOLM, Sweden, Aug. 30, 2005 (PRIMEZONE) -- Artimplant: CEO Tord Lendau and VP, Medical Affairs Elisabeth Liljensten will present the report for the period 1 January -- 30 June 2005 and Artimplant's proprietary technology Artelon(R).
The presentation will be in English
Date: Wednesday, August 31 Time: 10.00 a.m. CET
Dial in Number: +44 (0)20 7365 1849
A live broadcast of the telephone conference will be found on Artimplant's website www.artimplant.com
ARTIMPLANT
Artimplant's mission is to develop novel biodegradable materials and implants that meet the needs of patients, physicians and healthcare providers in orthopedics and other therapy areas. The company works together with global partners as a center of excellence in this development. Artimplant's vision is to become the partner of choice in biomaterials for hard and soft tissue repair in multiple therapy areas. Artimplant is a public company, listed on the Stockholm Exchange, O-list.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=125588&fn=wkr0001.pdf